ArticleBiomedicines2021

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300.

Mauro Rosales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.